Hepatic arterial infusion pump chemotherapy in patients with advanced intrahepatic cholangiocarcinoma confined to the liver: a multicenter phase II trial
Melek Rousian(Erasmus MC), Bas Groot Koerkamp, Bianca Mostert(Erasmus MC Cancer Institute), Rutger‐Jan Swijnenburg(Amsterdam University Medical Centers), M. Homs(Erasmus MC Cancer Institute), H.-J. Klümpen(Erasmus MC Cancer Institute), Lynn E. Nooijen(Amsterdam University Medical Centers), Jeroen Hagendoorn(Utrecht University), Nadia Haj Mohammad(Utrecht University), B. Ten Haaft(Amsterdam University Medical Centers), Michail Doukas(Erasmus MC), S. Franssen(Erasmus MC), A. Moelker(Erasmus University Rotterdam)
Cited by 0
Related Papers
FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis
|The Lancet Oncology|2016|914
Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2): a multicentre, patient-blinded, randomised controlled phase 2/3 trial
|The Lancet. Gastroenterology & hepatology|2019|597
Surgery for cholangiocarcinoma
|Liver International|2019|338
Embryonic Stem Cell Immunogenicity Increases Upon Differentiation After Transplantation Into Ischemic Myocardium
|Circulation|2005|332
Impact of resection margin status on recurrence and survival in pancreatic cancer surgery
|British journal of surgery|2019|225